Imatinib (Pyridine)-N-oxide

CAS: 571186-92-0

Rif. TR-I268010

Informazioni sul prodotto

• Nome: Imatinib (Pyridine)-N-oxide
• Sinonimi: N-[4-Methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide, CGP 72383, Benzamide, N-[4-methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-

Descrizione

Applications matinib (Pyridine)-N-oxide is an impurity of Imatinib (Gleevec) (G407000). Imatinib impurity A. It is a COVID19-related research product.
References Dagher, R., et al.: Clin. Cancer Res., 8, 3034 (2002), Chourasia, M., et al.: J. Pharm. Pharm. Sci., 6, 33 (2003), Deininger, M., et al.: J. Clin. Oncol., 21, 1637 (2003), Gschwind, H., et al.: Drug Metab. Dispos., 33, 1503 (2005),

• Marchio: TRC

Proprietà chimiche

• Peso molecolare: 509.60
• Formula: C₂₉H₃₁N₇O₂
• Colore/Forma: Light Yellow To Yellow
• InChI: InChI=1S/C29H31N7O2/c1-21-5-10-25(18-27(21)33-29-30-12-11-26(32-29)24-4-3-13-36(38)20-24)31-28(37)23-8-6-22(7-9-23)19-35-16-14-34(2)15-17-35/h3-13,18,20H,14-17,19H2,1-2H3,(H,31,37)(H,30,32,33)
• SMILES: Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2ccc[n+]([O-])c2)n1